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Allergic contact dermatitis occurs in
40–82.5% of patients with venous
insufficiency of the lower limbs,
mainly because of lanolin (wool alco-
hols), fragrances, and antimicrobial
agents (1–4). However, other aller-
gens may be involved, as in the cases
reported below.
Case Reports
We investigated 7 patients, 4 men and
3 women (ages 47–75 years, mean
66.5 years), with venous insufficiency
and associated leg ulcers lasting for
more than one year. They all pre-
sented with acute or subacute eczema
of the lower limbs, extending from
the dorsum of the foot to the upper
leg or thigh, with a sharp upper limit
(Fig. 1). The area around their ulcers,
where additional gauze protection
was being applied, was relatively free
of eczema.
Patch testing was undertaken with
the Portuguese baseline series of con-
tact allergens, topical medicament
series, and leg ulcer dressings used
by the patients. Allergens were
applied in Finn Chambers, Epitest
Ltd, and readings were performed at
D2 and D3 or D4 according to the
International Contact Dermatitis
Research Group (ICDRG) guide-
lines. All patients reacted to rubber
components – carba mix (5), thiuram
mix (6), and/or mercapto mix (1) and
to its constituents and 6 of them to
other allergens as well (Table 1).
As all patients were sensitized
to rubber components and their
leg dermatitis had an upper limit
coinciding with the bandages they
had been using, we performed fur-
ther patch tests with samples of the
high compression bandages and the
elastic tubular net Bend-a-Rete
(3M Company, Minnesota, USA)
they had been using, with positive
results (þ/þþ) in all of them
(Table 1).
After modification of topical med-
icaments according to the patch test
results, an improvement of their derma-
titis was seen. However, some areas
of eczema, namely those localized to
the upper leg and thigh, only resolved
when the rubber-containing ban-
dages and tubular net were avoided
or thicker cotton gauze was applied
under the compressive bandages.
Ulcer healing improved thereafter.
There was no apparent other expla-
nation for rubber dermatitis in these
patients.
Discussion
Although they are not among the
most common sensitizers, positive
patch tests to rubber components
occur in 11–15.6% of patients with
leg ulcers (1–3, 6). They are consid-
ered important sensitizers in this set-
ting with exposure being repeated
contact with gloves used by health-
care personnel and rubber-containing
compression bandages used in venous
insufficiency (1, 3, 5). Although we
were unable to obtain information
on the rubber components used in
the elastic tubular net and compres-
sion bandages, positive patch tests to
samples of them and improvement of
the dermatitis upon skin protection
by cotton gauze under the elastic
compression are strong arguments in
favour of their association with the
allergic contact dermatitis in these
patients.
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Fig. 1. Eczema surrounding the ulcer and extending to the thigh with a sharp
upper limit coinciding with the upper limit of the elastic compression bandage.
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